Patents by Inventor Stefan Johannes LEHNER

Stefan Johannes LEHNER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANGIOTENSIN II RECEPTOR ANTAGONIST FOR THE PREVENTION OR TREATMENT OF SYSTEMIC DISEASES IN CATS
    Publication number: 20210106564
    Abstract: A method is described for the prophylaxis or treatment of hypertension in a cat in need of such treatment. The method includes administration of a therapeutically effective amount of angiotensin II receptor 1 (AT-1) antagonist (sartan) to the cat, where the therapeutically effective amount of the sartan is administered in a daily dosage amount that is varied over a treatment period, the daily dosage amount of the sartan for a first period of time during the treatment period is 1.0 to 5.0 mg/kg of body weight, and the daily dosage amount of the sartan is decreased for a second period of time subsequent the first period of time during the treatment period.
    Type: Application
    Filed: December 22, 2020
    Publication date: April 15, 2021
    Inventors: Balazs ALBRECHT, Sven ANKE, Saskia KLEY, Stefan Johannes LEHNER, Marcus STARK, Anne Michelle TRAAS, Tanja Margrit ZIMMERING
  • Angiotensin II receptor antagonist for the prevention or treatment of systemic diseases in cats
    Patent number: 10905676
    Abstract: A method is described for the prophylaxis or treatment of hypertension in a cat in need of such treatment. The method includes administration of a therapeutically effective amount of angiotensin II receptor 1 (AT-1) antagonist (sartan) to the cat, where the therapeutically effective amount of the sartan is administered in a daily dosage amount that is varied over a treatment period, the daily dosage amount of the sartan for a first period of time during the treatment period is 1.0 to 5.0 mg/kg of body weight, and the daily dosage amount of the sartan is decreased for a second period of time subsequent the first period of time during the treatment period.
    Type: Grant
    Filed: July 5, 2018
    Date of Patent: February 2, 2021
    Inventors: Sven Anke, Stefan Johannes Lehner
  • ANGIOTENSIN II RECEPTOR ANTAGONIST FOR THE PREVENTION OR TREATMENT OF SYSTEMIC DISEASES IN CATS
    Publication number: 20190008831
    Abstract: A method is described for the prophylaxis or treatment of hypertension in a cat in need of such treatment. The method includes administration of a therapeutically effective amount of angiotensin II receptor 1 (AT-1) antagonist (sartan) to the cat, where the therapeutically effective amount of the sartan is administered in a daily dosage amount that is varied over a treatment period, the daily dosage amount of the sartan for a first period of time during the treatment period is 1.0 to 5.0 mg/kg of body weight, and the daily dosage amount of the sartan is decreased for a second period of time subsequent the first period of time during the treatment period.
    Type: Application
    Filed: July 5, 2018
    Publication date: January 10, 2019
    Inventors: Balazs ALBRECHT, Sven ANKE, Saskia KLEY, Stefan Johannes LEHNER, Marcus STARK, Anne Michelle TRAAS, Tanja Margrit ZIMMERING